Hitomi Okuma-Sumiyoshi
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway.
Journal: Oncogene
Published: September 13, 2024
Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: June 24, 2024
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway.
Journal: Oncogene
Published: January 14, 2024
Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation.
Journal: International cancer conference journal
Published: May 26, 2023
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: May 19, 2023
COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation.
Journal: International cancer conference journal
Published: December 13, 2022
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: August 11, 2022
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer.
Journal: British journal of cancer
Published: June 19, 2022
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.
Journal: BMC cancer
Published: January 30, 2022
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study.
Journal: BMC cancer
Published: March 19, 2021
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment.
Journal: Medicine
Published: September 22, 2020
Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Journal: Medical oncology (Northwood, London, England)
Published: March 26, 2019
Last Updated: 09/26/2026